Black Diamond Therapeutics Inc (NAS:BDTX)
$ 1.71 +0.010 (+0.59%) Market Cap: 97.99 Mil Enterprise Value: -2.39 Mil PE Ratio: 0 PB Ratio: 0.94 GF Score: 38/100

Black Diamond Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 26, 2026 / 01:00PM GMT
Release Date Price: $1.71 (+0.59%)
Operator

Hello and welcome to the 2026 Virtual Annual Meeting of Black Diamond Therapeutics, Inc. Please note that today's meeting is being recorded. Stockholders may submit questions by following the instructions on the Annual Meeting interface.

I would like to turn the meeting over to Mark Velleca, the Chair of the Annual Meeting.

Mark Velleca
Black Diamond Therapeutics Inc - Chairman of the Board, President, Chief Executive Officer

Good morning, everyone. My name is Mark Velleca, President, CEO, and Chair of the Board of Directors of Black Diamond Therapeutics. The meeting is now called to order. I've asked Karen Yu of Goodwin Procter, our outside legal counsel, to record the minutes.

It is a pleasure to welcome our stockholders and visitors to the 2026 Annual Meeting of Stockholders, Black Diamond Therapeutics. This meeting is being held in accordance with the company's bylaws and Delaware law.

We are conducting the annual meeting virtually instead of in person in order to facilitate the attendance and participation of our stockholders

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot